title: Low prevalence of depressive disorder in ambulatory advanced cancer patients using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN 2.1).
abstract: Depressive disorder is assumed to be highly prevalent in advanced cancer patients, but the diagnosis of depressive disorder in patients with advanced cancer is difficult. The more robust the assessment instrument to diagnose depressive disorder is, the lower the reported prevalence of depressive disorder in advanced cancer patients. This study confirms a low prevalence of depressive disorder (3%) in 64 advanced cancer outpatients using a robust structured clinical assessment (SCAN 2.1). Furthermore, in this article we discuss possible implications of using predefined psychiatric labeling in the assessment of mood symptoms in advanced cancer patients.
authors.affiliation: Radboud University Nijmegen Medical Centre, Department of Primary and Community Care, Nijmegen, The Netherlands. f.warmenhoven@anes.umcn.nl
authors.forename: Franca
authors.initials: F
authors.lastname: Warmenhoven
authors.forename: Eric
authors.initials: E
authors.lastname: van Rijswijk
authors.forename: Chris
authors.initials: C
authors.lastname: van Weel
authors.forename: Judith
authors.initials: J
authors.lastname: Prins
authors.forename: Kris
authors.initials: K
authors.lastname: Vissers
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000523:psychology*; D009426:Netherlands; D010045:Outpatients / Q000523:psychology*; D015995:Prevalence